Cargando…
Emerging Therapeutic Activity of Davallia formosana on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression
Background: Prostate cancer (PCa) is the most prevalent malignancy diagnosed in men in Western countries. There is currently no effective therapy for advanced PCa aggressiveness, including castration-resistant progression. The aim of this study is to evaluate the potential efficacy and determine the...
Autores principales: | Hsieh, Po-Fan, Jiang, Wen-Ping, Huang, Shih-Yin, Basavaraj, Praveenkumar, Wu, Jin-Bin, Ho, Hui-Ya, Huang, Guan-Jhong, Huang, Wen-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226131/ https://www.ncbi.nlm.nih.gov/pubmed/32276528 http://dx.doi.org/10.3390/cancers12040914 |
Ejemplares similares
-
Evaluation of the Antihyperuricemic Activity of Phytochemicals from Davallia formosana by Enzyme Assay and Hyperuricemic Mice Model
por: Chen, Chen-Yu, et al.
Publicado: (2014) -
Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis
por: Basavaraj, Praveenkumar, et al.
Publicado: (2022) -
(−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2017) -
Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation
por: Lin, Tzu-Hung, et al.
Publicado: (2013) -
Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis
por: Gu, Yue, et al.
Publicado: (2021)